Extramedullary relapse and discordant CD19 expression between bone marrow and extramedullary sites in relapsed acute lymphoblastic leukemia after blinatumomab treatment
Christos Demosthenous(G. Papanikolaou General Hospital), Αchilles Anagnostopoulos(G. Papanikolaou General Hospital), Nikoleta Pastelli(Aristotle University of Thessaloniki), Vassiliki Douka(G. Papanikolaou General Hospital), Michalis Iskas(G. Papanikolaou General Hospital), Chrysavgi Lalayanni(G. Papanikolaou General Hospital)
Cited by 26
Related Papers
Is there a role for antigen selection in mantle cell lymphoma? Immunogenetic support from a series of 807 cases
|Blood|2011|178
COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study
|Leukemia|2021|94
Genetic prediction of ICU hospitalization and mortality in COVID‐19 patients using artificial neural networks
|Journal of Cellular and Molecular Medicine|2022|90
Genetic justification of severe COVID-19 using a rigorous algorithm
|Clinical Immunology|2021|63
Beta-thalassemia: renal complications and mechanisms: a narrative review
|Hematology|2019|62